Agid, O, Siu, CO, Pappadopulos, E, Vanderburg, D and Remington, G (2013) Early prediction of clinical and functional outcome in schizophrenia. European Neuropsychopharmacology 23, 842–851.
Andreasen, NC, Carpenter, WT Jr, Kane, JM, Lasser, RA, Marder, SR and Weinberger, DR (2005) Remission in schizophrenia: proposed criteria and rationale for consensus. American Journal of Psychiatry 162, 441–449.
Bottlender, R, Strauss, A and Möller, HJ (2010) Social disability in schizophrenic, schizoaffective and affective disorders 15 years after first admission. Schizophrenia Research 116, 9–15.
Colizzi, M, Carra, E, Fraietta, S, Lally, J, Quattrone, D, Bonaccorso, S, Mondelli, V, Ajnakina, O, Dazzan, P, Trotta, A, Sideli, L, Kolliakou, A, Gaughran, F, Khondoker, M, David, AS, Murray, RM, MacCabe, JH and Di Forti, M (2016) Substance use, medication adherence and outcome one year following a first episode of psychosis. Schizophrenia Research 170, 311–317.
Craig, T, Fennig, S, Tanenberg-Karant, M and Bromet, EJ (1999) Six-month clinical status as a predictor of 24-month clinical outcome in first-admission patients with schizophrenia. Annals of Clinical Psychiatry 11, 197–203.
Crumlish, N, Whitty, P, Clarke, M, Browne, S, Kamali, M, Gervin, M, McTigue, O, Kinsella, A, Waddington, JL, Larkin, C and O'Callaghan, E (2009) Beyond the critical period: longitudinal study of 8-year outcome in first-episode non-affective psychosis. British Journal of Psychiatry 194, 18–24.
Demjaha, A, Morgan, K, Morgan, C, Landau, S, Dean, K, Reichenberg, A, Sham, P, Fearon, P, Hutchinson, G, Jones, PB, Murray, RM and Dazzan, P (2009) Combining dimensional and categorical representation of psychosis: the way forward for DSM-V and ICD-11? Psychological Medicine 39, 1943–1955.
Emsley, R, Oosthuizen, PP, Kidd, M, Koen, L, Niehaus, DJ and Turner, HJ (2006) Remission in first-episode psychosis: predictor variables and symptom improvement patterns. Journal of Clinical Psychiatry 67, 1707–1712.
Endicott, J, Spitzer, RL, Fleiss, JL and Cohen, J (1976) The global assessment scale: a procedure for measuring overall severity of psychiatric disturbance. Archives of General Psychiatry 33, 766–771.
Friis, S, Melle, I, Johannessen, JO, Røssberg, JI, Barder, HE, Evensen, JH, Haahr, U, Ten Velden Hegelstad, W, Joa, I, Langeveld, J, Larsen, TK, Opjordsmoen, S, Rund, BR, Simonsen, E, Vaglum, PW and McGlashan, TH (2016) Early predictors of ten-year course in first-episode psychosis. Psychiatric Services 67, 438–443.
Harrison, G, Hopper, K, Craig, T, Laska, E, Siegel, C, Wanderling, J, Dube, KC, Ganev, K, Giel, R, an der Heiden, W, Holmberg, SK, Janca, A, Lee, PW, León, CA, Malhotra, S, Marsella, AJ, Nakane, Y, Sartorius, N, Shen, Y, Skoda, C, Thara, R, Tsirkin, SJ, Varma, VK, Walsh, D and Wiersma, D (2001) Recovery from psychotic illness: a 15- and 25-year international follow-up study. British Journal of Psychiatry 178, 506–517.
Hegelstad, WT, Larsen, TK, Auestad, B, Evensen, J, Haahr, U, Joa, I, Johannesen, JO, Langeveld, J, Melle, I, Opjordsmoen, S, Rossberg, JI, Rund, BR, Simonsen, E, Sundet, K, Vaglum, P, Friis, S and McGlashan, T (2012) Long-term follow-up of the TIPS early detection in psychosis study: effects on 10-year outcome. American Journal of Psychiatry 169, 374–380.
Henry, LP, Amminger, GP, Harris, MG, Yuen, HP, Harrigan, SM, Prosser, AL, Schwartz, OS, Farrelly, SE, Herrman, H, Jackson, HJ and McGorry, PD (2010) The EPPIC follow-up study of first-episode psychosis: longer-term clinical and functional outcome 7 years after index admission. Journal of Clinical Psychiatry 71, 716–728.
Jablensky, A, Sartorius, N, Ernberg, G, Anker, M, Korten, A, Cooper, JE, Day, R and Bertelsen, A (1992) Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organisation ten-country study. Psychological Medicine Monograph Supplement 20, 1–97.
Johnstone, EC, Owens, DG, Bydder, GM, Colter, N, Crow, TJ and Frith, CD (1989) The spectrum of structural brain changes in schizophrenia: age of onset as a predictor of cognitive and clinical impairments and their cerebral correlates. Psychological Medicine 19, 91–103.
Jordan, G, Lutgens, D, Joober, R, Lepage, M, Iyer, SN and Malla, A (2014) The relative contribution of cognition and symptomatic remission to functional outcome following treatment of a first episode of psychosis. Journal of Clinical Psychiatry 75, e566–e572.
Judd, LL, Akiskal, HS, Schettler, PJ, Endicott, J, Leon, AC, Solomon, DA, Coryell, W, Maser, JD and Keller, MB (2005) Psychosocial disability in the course of bipolar I and II disorders: a prospective, comparative, longitudinal study. Archives of General Psychiatry 62, 1322–1330.
Kinon, BJ, Chen, L, Ascher-Svanum, H, Stauffer, VL, Kollack-Walker, S, Zhou, W, Kapur, S and Kane, JM (2010) Early response to antipsychotic drug therapy as a clinical marker of subsequent response in the treatment of schizophrenia. Neuropsychopharmacology 35, 581–590.
Lambert, M, Conus, P, Lubman, DI, Wade, D, Yuen, H, Moritz, S, Naber, D, McGorry, PD and Schimmelmann, BG (2005) The impact of substance use disorders on clinical outcome in 643 patients with first-episode psychosis. Acta psychiatrica Scandinavica 112, 141–148.
Leung, A and Chue, P (2000) Sex differences in schizophrenia, a review of the literature. Acta Psychiatrica Scandinavica Supplement 401, 3–38.
Lieberman, J, Jody, D, Geisler, S, Alvir, J, Loebel, A, Szymanski, S, Woerner, M and Borenstein, M (1993) Time course and biologic correlates of treatment response in first-episode schizophrenia. Archives of General Psychiatry 50, 369–376.
Marneros, A, Deister, A and Rohde, A (1990) Psychopathological and social status of patients with affective, schizophrenic and schizoaffective disorders after long-term course. Acta Psychiatrica Scandinavica 82, 352–358.
Marshall, M, Lewis, S, Lockwood, A, Drake, R, Jones, P and Croudace, T (2005) Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Archives of General Psychiatry 62, 975–983.
Miller, BJ (2008) A review of second-generation antipsychotic discontinuation in first-episode psychosis. Journal of Psychiatric Practice 14, 289–300.
Morgan, C, Dazzan, P, Morgan, K, Jones, P, Harrison, G, Leff, J, Murray, R and Fearon, P and AESOP study group (2006) First episode psychosis and ethnicity: initial findings from the AESOP study. World Psychiatry 5, 40–46.
Morgan, C, Lappin, J, Heslin, M, Donoghue, K, Lomas, B, Reininghaus, U, Onyejiaka, A, Croudace, T, Jones, PB, Murray, RM, Fearon, P, Doody, GA and Dazzan, P (2014) Reappraising the long-term course and outcome of psychotic disorders: the AESOP-10 study. Psychological Medicine 44, 2713–2726.
Morgan, C, Fearon, P, Lappin, J, Heslin, M, Donoghue, K, Lomas, B, Reininghaus, U, Onyejiaka, A, Croudace, T, Jones, PB, Murray, RM, Doody, GA and Dazzan, P (2017) Ethnicity and long-term course and outcome of psychotic disorders: the ÆSOP-10 study. British Journal of Psychiatry 211, 88–94.
Petersen, L, Jeppesen, P, Thorup, A, Abel, MB, Øhlenschlaeger, J, Christensen, TØ, Krarup, G, Jørgensen, P and Nordentoft, M (2005) A randomised multicentre trial of integrated versus standard treatment for patients with a first episode of psychotic illness. British Medical Journal 331, 602.
Rabinowitz, J, Levine, SZ and Häfner, H (2006) A population based elaboration of the role of age of onset on the course of schizophrenia. Schizophrenia Research 88, 96–101.
Racenstein, JM, Harrow, M, Reed, R, Martin, E, Herbener, E and Penn, DL (2002) The relationship between positive symptoms and instrumental work functioning in schizophrenia: a 10 year follow-up study. Schizophrenia Research 56, 95–103.
Robinson, DG, Woerner, MG, Alvir, JM, Bilder, RM, Hinrichsen, GA and Lieberman, JA (1999) Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder. American Journal of Psychiatry 156, 544–549.
Sartorius, N, Gulbinat, W, Harrison, G, Laska, E and Siegel, C (1996) Long-term follow-up of schizophrenia in 16 countries. A description of the International Study of Schizophrenia conducted by the World Health Organization. Social Psychiatry and Psychiatric Epidemiology 31, 249–258.
Susser, E, Finnerty, M, Mojtabai, R, Yale, S, Conover, S, Goetz, R and Amador, X (2000) Reliability of the life chart schedule for assessment of the long-term course of schizophrenia. Schizophrenia Research 42, 67–77.
Thara, R, Henrietta, M, Joseph, A, Rajikumar, S and Eaton, WW (1994) Ten-year course of schizophrenia – the Madras longitudinal study. Acta psychiatrica Scandinavica 90, 329–336.
van Os, J, Wright, P and Murray, R (1997) Follow-up studies of schizophrenia I: Natural history and non-psychopathological predictors of outcome. European Psychiatry 12, 327s–341s.
Verma, S, Subramaniam, M, Abdin, E, Poon, LY and Chong, SA (2012) Symptomatic and functional remission in patients with first-episode psychosis. Acta Psychiatrica Scandinavica 126, 282–289.
Weibell, MA, Hegelstad, WTV, Auestad, B, Bramness, J, Evensen, J, Haahr, U, Joa, I, Johannessen, JO, Larsen, TK, Melle, I, Opjordsmoen, S, Rund, BR, Simonsen, E, Vaglum, P, McGlashan, T, McGorry, P and Friis, S (2017) The effect of substance use on 10-year outcome in first-episode psychosis. Schizophrenia Bulletin 43, 843–851.
White, C, Stirling, J, Hopkins, R, Morris, J, Montague, L, Tantam, D and Lewis, S (2009) Predictors of 10-year outcome of first-episode psychosis. Psychological Medicine 39, 1447–1456.
Wiersma, D, Nienhuis, FJ, Slooff, CJ and Giel, R (1998) Natural course of schizophrenic disorders: a 15-year follow-up of a Dutch incidence cohort. Schizophrenia Bulletin 24, 75–85.
World Health Organization (WHO) (1992) Schedules for Clinical Assessment in Neuropsychiatry. Geneva: World Health Organization.